Since 1964, Tatarinov et al. found a strong correlation between a high concentration of AFP and the diagnosis of HCC and further investigations demonstrated that AFP is a sensitive marker for HCC diagnosis, its efficacy evaluation, and prognosis [106,107]. The gene discussed is AFP; the disease is hepatocellular carcinoma.